Sfoglia per Autore
Predictors Of Vandetanib Response In The Locally Advanced Or Metastatic Medullary Thyroid Cancer: A Single Center Experience
2016-01-01 Valerio, Laura; Bottici, Valeria; Matrone, Antonio; Tacito, Alessia; Casella, Francesca; Romei, Cristina; Vitti, Paolo; Elisei, Rossella
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience
2016-01-01 Viola, David; Valerio, Laura; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Biagini, Agnese; Lorusso, Loredana; Cappagli, Virginia; Pieruzzi, Letizia; Giani, Carlotta; Sabini, Elena; Passannati, Paolo; Puleo, Luciana; Matrone, Antonio; PONTILLO CONTILLO, Benedetta; Battaglia, Valentina; Mazzeo, Salvatore; Vitti, Paolo; Elisei, Rossella
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations
2016-01-01 Romei, Cristina; Casella, Francesca; Tacito, Alessia; Bottici, Valeria; Valerio, Laura; Viola, David; Cappagli, Virginia; Matrone, Antonio; Ciampi, Raffaele; Piaggi, Paolo; Ugolini, Clara; Torregrossa, Liborio; Basolo, Fulvio; Materazzi, Gabriele; Vitti, Paolo; Elisei, Rossella
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT)
2017-01-01 Cappagli, Virginia; Meli, Sonia; Matrone, Antonio; Bottici, Valeria; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Materazzi, Gabriele; Elisei, Rossella
Postoperative thyroglobulin and neck ultrasound in the risk restratification and decision to perform ¹³¹l ablation
2017-01-01 Matrone, Antonio; Gambale, Carla; Piaggi, Paolo; Viola, David; Giani, Carlotta; Agate, Laura; Bottici, Valeria; Bianchi, Francesca; Materazzi, Gabriele; Vitti, Paolo; Molinaro, Eleonora; Elisei, Rossella
Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center
2017-01-01 Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Marcocci, Claudio; Vitti, Paolo; Elisei, Rossella; Molinaro, Eleonora
V804M RET MUTATION AND VANDETANIB RESPONSE IN METASTATIC MEDULLARY THYROID CANCER
2017-01-01 Valerio, Laura; Bottici, Valeria; Matrone, Antonio; Tacito, Alessia; Casella, Francesca; Romei, Cristina; Vitti, Paolo; Elisei, Rossella
Thyroglobulin Antibodies (TgAb) Titer Spontaneously Decrease Until The Negativization Or Stabilization In Most Of Cases Of Papillary Thyroid Microcarcinoma (mPTC) Treated With Total Thyroidectomy But Not Ablated With 131I
2017-01-01 Matrone, Antonio; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Valerio, Laura; Lorusso, Loredana; Faranda, Alessio; Piaggi, Paolo; Vitti, Paolo; Elisei, Rossella
Mutazione V804M di RET nel carcinoma midollare della tiroide e risposta al trattamento con vandetanib
2017-01-01 Valerio, Laura; Bottici, Valeria; Matrone, Antonio; Tacito, Alessia; Casella, Francesca; Romei, Cristina; Pontillo Contillo, Benedetta; Mazzeo, Salvatore; Vitti, Paolo; Elisei, Rossella
Targeted Therapy in Thyroid Cancer: State of the Art
2017-01-01 Valerio, Laura; Pieruzzi, Letizia; Giani, Carlotta; Agate, Laura; Bottici, Valeria; Lorusso, Loredana; Cappagli, Virginia; Puleo, Luciana; Matrone, Antonio; Viola, David; Romei, Cristina; Ciampi, Raffaele; Molinaro, Eleonora; Elisei, Rossella
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib
2018-01-01 Giani, C.; Valerio, L.; Pieruzzi, L.; Agate, L.; Viola, D.; Bottici, V.; Piaggi, P.; Lorusso, L.; Cappagli, V.; Puleo, L.; Matrone, A.; Mazzeo, S.; Ribechini, A.; Vitti, P.; Molinaro, E.; Elisei, Rossella
Impact of the Stimulation method Used for 131-Therapy in Patients With Differentiated Thyroid Cancer.
2018-01-01 Addante, E; Giani, C; Bianchi, F; Brozzi, F; Santini, P; Agate, L; Viola, D; Bottici, V; Vitti, P; Elisei, E; Molinaro, E.
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment.
2018-01-01 Viola, D; Agate, L; Molinaro, E; Bottici, V; Lorusso, L; Latrofa, F; Torregrossa, L; Boldrini, L; Ramone, Teresa; Vitti, P; Elisei, R.
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre
2018-01-01 Giani, C; Valerio, L; Pieruzzi, L; Agate, L; Viola, D; Bottici, V; Piaggi, P; Lorusso, L; Cappagli, V; Puleo, L; Matrone, A; Mazzeo, S; Pontillo-Contillo, B; Ribechini, A; Vitti, P; Molinaro, E; Elisei, R.
Vandetanib and the predictive factors of durable response in locally advanced or metastatic medullary thyroid cancer: a single center experience.
2019-01-01 Valerio, Laura; Bottici, Valeria; Matrone, Antonio; Tacito, Alessia; Romei, Cristina; Piaggi, Paolo; Molinaro, Eleonora; Elisei, Rossella
Predictive factors of short and long-term vandetanib response in locally advanced or metastatic medullary thyroid cancer: a single center experience
2019-01-01 Valerio, Laura; Bottici, Valeria; Matrone, Antonio; Tacito, Alessia; Romei, Cristina; Piaggi, Paolo; Elisei, Rossella
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations
2019-01-01 Elisei, Rossella; Tacito, Alessia; Ramone, Teresa; Ciampi, Raffaele; Bottici, Valeria; Cappagli, Virginia; Viola, David; Matrone, Antonio; Lorusso, Loredana; Valerio, Laura; Giani, Carlotta; Campopiano, Cristina; Prete, Alessandro; Agate, Laura; Molinaro, Eleonora; Romei, Cristina
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases
2019-01-01 Elisei, R; Matrone, A; Valerio, L; Molinaro, E; Agate, L; Bottici, V; Viola, D; Giani, C; Cappagli, V; Latrofa, F; Materazzi, G; Torregrossa, L; Ugolini, C; Basolo, F; Romei, C.
Less than 2% of the low- and intermediate-risk differentiated thyroid cancers show distant metastases at post-ablation whole-body scan
2019-01-01 Agate, L.; Bianchi, Francesca; Brozzi, F.; Santini, P.; Molinaro, E.; Bottici, V.; Viola, D.; Lorusso, L.; Vitti, P.; Elisei, R.
Lenvatinib treatment in the real clinical practice of progressive, radioiodine-refractory differentiated thyroid carcinoma: analysis of a big series followed in a single center
2019-01-01 Giani, Carlotta; Valerio, Laura; Agate, Laura; Viola, David; Bottici, Valeria; Lorusso, Loredana; Cappagli, Virginia; Matrone, Antonio; Materazzi, Gabriele; Mazzeo, Salvatore; Ribechini, Alessandro; Vitti, Paolo; Molinaro, Eleonora; Elisei, Rossella
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Predictors Of Vandetanib Response In The Locally Advanced Or Metastatic Medullary Thyroid Cancer: A Single Center Experience | 1-gen-2016 | Valerio, Laura; Bottici, Valeria; Matrone, Antonio; Tacito, Alessia; Casella, Francesca; Romei, Cristina; Vitti, Paolo; Elisei, Rossella | |
| Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience | 1-gen-2016 | Viola, David; Valerio, Laura; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Biagini, Agnese; Lorusso, Loredana; Cappagli, Virginia; Pieruzzi, Letizia; Giani, Carlotta; Sabini, Elena; Passannati, Paolo; Puleo, Luciana; Matrone, Antonio; PONTILLO CONTILLO, Benedetta; Battaglia, Valentina; Mazzeo, Salvatore; Vitti, Paolo; Elisei, Rossella | |
| New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations | 1-gen-2016 | Romei, Cristina; Casella, Francesca; Tacito, Alessia; Bottici, Valeria; Valerio, Laura; Viola, David; Cappagli, Virginia; Matrone, Antonio; Ciampi, Raffaele; Piaggi, Paolo; Ugolini, Clara; Torregrossa, Liborio; Basolo, Fulvio; Materazzi, Gabriele; Vitti, Paolo; Elisei, Rossella | |
| Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) | 1-gen-2017 | Cappagli, Virginia; Meli, Sonia; Matrone, Antonio; Bottici, Valeria; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Materazzi, Gabriele; Elisei, Rossella | |
| Postoperative thyroglobulin and neck ultrasound in the risk restratification and decision to perform ¹³¹l ablation | 1-gen-2017 | Matrone, Antonio; Gambale, Carla; Piaggi, Paolo; Viola, David; Giani, Carlotta; Agate, Laura; Bottici, Valeria; Bianchi, Francesca; Materazzi, Gabriele; Vitti, Paolo; Molinaro, Eleonora; Elisei, Rossella | |
| Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center | 1-gen-2017 | Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Marcocci, Claudio; Vitti, Paolo; Elisei, Rossella; Molinaro, Eleonora | |
| V804M RET MUTATION AND VANDETANIB RESPONSE IN METASTATIC MEDULLARY THYROID CANCER | 1-gen-2017 | Valerio, Laura; Bottici, Valeria; Matrone, Antonio; Tacito, Alessia; Casella, Francesca; Romei, Cristina; Vitti, Paolo; Elisei, Rossella | |
| Thyroglobulin Antibodies (TgAb) Titer Spontaneously Decrease Until The Negativization Or Stabilization In Most Of Cases Of Papillary Thyroid Microcarcinoma (mPTC) Treated With Total Thyroidectomy But Not Ablated With 131I | 1-gen-2017 | Matrone, Antonio; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Valerio, Laura; Lorusso, Loredana; Faranda, Alessio; Piaggi, Paolo; Vitti, Paolo; Elisei, Rossella | |
| Mutazione V804M di RET nel carcinoma midollare della tiroide e risposta al trattamento con vandetanib | 1-gen-2017 | Valerio, Laura; Bottici, Valeria; Matrone, Antonio; Tacito, Alessia; Casella, Francesca; Romei, Cristina; Pontillo Contillo, Benedetta; Mazzeo, Salvatore; Vitti, Paolo; Elisei, Rossella | |
| Targeted Therapy in Thyroid Cancer: State of the Art | 1-gen-2017 | Valerio, Laura; Pieruzzi, Letizia; Giani, Carlotta; Agate, Laura; Bottici, Valeria; Lorusso, Loredana; Cappagli, Virginia; Puleo, Luciana; Matrone, Antonio; Viola, David; Romei, Cristina; Ciampi, Raffaele; Molinaro, Eleonora; Elisei, Rossella | |
| Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib | 1-gen-2018 | Giani, C.; Valerio, L.; Pieruzzi, L.; Agate, L.; Viola, D.; Bottici, V.; Piaggi, P.; Lorusso, L.; Cappagli, V.; Puleo, L.; Matrone, A.; Mazzeo, S.; Ribechini, A.; Vitti, P.; Molinaro, E.; Elisei, Rossella | |
| Impact of the Stimulation method Used for 131-Therapy in Patients With Differentiated Thyroid Cancer. | 1-gen-2018 | Addante, E; Giani, C; Bianchi, F; Brozzi, F; Santini, P; Agate, L; Viola, D; Bottici, V; Vitti, P; Elisei, E; Molinaro, E. | |
| Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. | 1-gen-2018 | Viola, D; Agate, L; Molinaro, E; Bottici, V; Lorusso, L; Latrofa, F; Torregrossa, L; Boldrini, L; Ramone, Teresa; Vitti, P; Elisei, R. | |
| Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre | 1-gen-2018 | Giani, C; Valerio, L; Pieruzzi, L; Agate, L; Viola, D; Bottici, V; Piaggi, P; Lorusso, L; Cappagli, V; Puleo, L; Matrone, A; Mazzeo, S; Pontillo-Contillo, B; Ribechini, A; Vitti, P; Molinaro, E; Elisei, R. | |
| Vandetanib and the predictive factors of durable response in locally advanced or metastatic medullary thyroid cancer: a single center experience. | 1-gen-2019 | Valerio, Laura; Bottici, Valeria; Matrone, Antonio; Tacito, Alessia; Romei, Cristina; Piaggi, Paolo; Molinaro, Eleonora; Elisei, Rossella | |
| Predictive factors of short and long-term vandetanib response in locally advanced or metastatic medullary thyroid cancer: a single center experience | 1-gen-2019 | Valerio, Laura; Bottici, Valeria; Matrone, Antonio; Tacito, Alessia; Romei, Cristina; Piaggi, Paolo; Elisei, Rossella | |
| Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations | 1-gen-2019 | Elisei, Rossella; Tacito, Alessia; Ramone, Teresa; Ciampi, Raffaele; Bottici, Valeria; Cappagli, Virginia; Viola, David; Matrone, Antonio; Lorusso, Loredana; Valerio, Laura; Giani, Carlotta; Campopiano, Cristina; Prete, Alessandro; Agate, Laura; Molinaro, Eleonora; Romei, Cristina | |
| Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases | 1-gen-2019 | Elisei, R; Matrone, A; Valerio, L; Molinaro, E; Agate, L; Bottici, V; Viola, D; Giani, C; Cappagli, V; Latrofa, F; Materazzi, G; Torregrossa, L; Ugolini, C; Basolo, F; Romei, C. | |
| Less than 2% of the low- and intermediate-risk differentiated thyroid cancers show distant metastases at post-ablation whole-body scan | 1-gen-2019 | Agate, L.; Bianchi, Francesca; Brozzi, F.; Santini, P.; Molinaro, E.; Bottici, V.; Viola, D.; Lorusso, L.; Vitti, P.; Elisei, R. | |
| Lenvatinib treatment in the real clinical practice of progressive, radioiodine-refractory differentiated thyroid carcinoma: analysis of a big series followed in a single center | 1-gen-2019 | Giani, Carlotta; Valerio, Laura; Agate, Laura; Viola, David; Bottici, Valeria; Lorusso, Loredana; Cappagli, Virginia; Matrone, Antonio; Materazzi, Gabriele; Mazzeo, Salvatore; Ribechini, Alessandro; Vitti, Paolo; Molinaro, Eleonora; Elisei, Rossella |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile